Corcept Therapeutics Incorporated announced the appointment of Monica Tellado as President, Emerging Markets. She will report to Joseph K. Belanoff, MD, Corcept’s Chief Executive Officer, and join the company’s Executive Team. Ms. Tellado’s prior role was at Heartflow, where she served as Chief Financial Officer. At Corcept, Ms. Tellado will serve as the global commercial lead for therapeutics in metabolism and neurology. She will also oversee pipeline and portfolio planning activities across the company’s other therapeutic areas.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CORT:
- Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
- Corcept Appoints Monica Tellado as President, Emerging Markets
- CORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Corcept Therapeutics initiates MONARCH trial
- Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)